Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
Authors
Keywords
-
Journal
Viruses-Basel
Volume 8, Issue 6, Pages 176
Publisher
MDPI AG
Online
2016-06-24
DOI
10.3390/v8060176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Naturally occurring HCV NS5A/B inhibitor resistance-associated mutations to direct-acting antivirals
- (2016) Linh Thuy Nguyen et al. ANTIVIRAL THERAPY
- Occludin-Knockout Human Hepatic Huh7.5.1-8-Derived Cells Are Completely Resistant to Hepatitis C Virus Infection
- (2016) Yoshitaka Shirasago et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies
- (2016) Catherine Fauvelle et al. GASTROENTEROLOGY
- Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
- (2016) Jean-Michel Pawlotsky GASTROENTEROLOGY
- The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
- (2016) Christoph Sarrazin JOURNAL OF HEPATOLOGY
- Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice
- (2016) Takuro Uchida et al. VIRUS RESEARCH
- Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment
- (2016) Sabrina Bagaglio et al. Viruses-Basel
- Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization
- (2016) Koen Vercauteren et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preclinical Characterization andIn VivoEfficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein
- (2015) Jeffrey J. Pouliot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination therapies with daclatasvir and asunaprevir on NS3-D168 mutated HCV in human hepatocyte chimeric mice
- (2015) Hiromi Kan et al. ANTIVIRAL THERAPY
- HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
- (2015) Jannick Prentoe et al. GUT
- Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis C virus-infected patients
- (2015) Kazuaki Chayama et al. HEPATOLOGY
- Hepatitis C virus drug resistance-associated substitutions: State of the art summary
- (2015) Erik Lontok et al. HEPATOLOGY
- Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
- (2015) Paula M. Perin et al. HEPATOLOGY
- HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b
- (2015) Yosuke Hirotsu et al. Hepatology International
- Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model
- (2015) Sara Calattini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort
- (2015) Samantha J. Shepherd et al. JOURNAL OF CLINICAL VIROLOGY
- Emergence of hepatitis C virus NS5A L31V plus Y93H variant upon treatment failure of daclatasvir and asunaprevir is relatively resistant to ledipasvir and NS5B polymerase nucleotide inhibitor GS-558093 in human hepatocyte chimeric mice
- (2015) Yugo Kai et al. JOURNAL OF GASTROENTEROLOGY
- G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice
- (2015) K. Vercauteren et al. JOURNAL OF HEPATOLOGY
- Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
- (2015) Oliver Lenz et al. JOURNAL OF HEPATOLOGY
- Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV
- (2015) Tânia Silva et al. JOURNAL OF MEDICAL VIROLOGY
- Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy
- (2015) Satoshi Yoshimi et al. JOURNAL OF MEDICAL VIROLOGY
- Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action
- (2015) Noémie Calland et al. JOURNAL OF VIROLOGY
- Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
- (2015) Masashi Mizokami et al. LANCET INFECTIOUS DISEASES
- Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A
- (2015) Jin-Hua Sun et al. NATURE
- Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody
- (2015) Laurent Mailly et al. NATURE BIOTECHNOLOGY
- Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin
- (2015) Vanesa Madan et al. Viruses-Basel
- Hepatitis C Virus Core Protein Suppresses Mitophagy by Interacting with Parkin in the Context of Mitochondrial Depolarization
- (2014) Yuichi Hara et al. AMERICAN JOURNAL OF PATHOLOGY
- Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors
- (2014) V. C. Di Maio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122
- (2014) Søren Ottosen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update on hepatitis C virus resistance to direct-acting antiviral agents
- (2014) Eva Poveda et al. ANTIVIRAL RESEARCH
- Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure
- (2014) Malcolm J. Macartney et al. ANTIVIRAL RESEARCH
- Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients
- (2014) Meike H. van der Ree et al. ANTIVIRAL RESEARCH
- Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype 1 patients with or without HIV coinfection
- (2014) Gaspar Lisboa-Neto et al. ANTIVIRAL THERAPY
- Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C
- (2014) Tanya L Applegate et al. ANTIVIRAL THERAPY
- Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice
- (2014) Jizheng Chen et al. CELL RESEARCH
- Cyclophilin Inhibitors Reduce Phosphorylation of RNA-Dependent Protein Kinase to Restore Expression of IFN-Stimulated Genes in HCV-Infected Cells
- (2014) Takuji Daito et al. GASTROENTEROLOGY
- Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir
- (2014) Eric F. Donaldson et al. HEPATOLOGY
- Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants within vitroresistance to SR-BI-targeting agents
- (2014) Koen Vercauteren et al. HEPATOLOGY
- Global distribution and prevalence of hepatitis C virus genotypes
- (2014) Jane P. Messina et al. HEPATOLOGY
- HCV animal models and liver disease
- (2014) Koen Vercauteren et al. JOURNAL OF HEPATOLOGY
- Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia
- (2014) Jameleddine Aissa Larousse et al. JOURNAL OF MEDICAL VIROLOGY
- Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1
- (2014) K. Kosaka et al. JOURNAL OF VIRAL HEPATITIS
- Inhibition of Hepatitis C Virus in Chimeric Mice by Short Synthetic Hairpin RNAs: Sequence Analysis of Surviving Virus Shows Added Selective Pressure of Combination Therapy
- (2014) A. Dallas et al. JOURNAL OF VIROLOGY
- Development and function of human innate immune cells in a humanized mouse model
- (2014) Anthony Rongvaux et al. NATURE BIOTECHNOLOGY
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extensive double humanization of both liver and hematopoiesis in FRGN mice
- (2014) Elizabeth M. Wilson et al. Stem Cell Research
- Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
- (2014) Moses T. Bility et al. PLoS Pathogens
- A Translational Study of Resistance Emergence Using Sequential Direct-Acting Antiviral Agents for Hepatitis C Using Ultra-Deep Sequencing
- (2013) Hiromi Abe et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Human Hepatocytes and Hematolymphoid Dual Reconstitution in Treosulfan-Conditioned uPA-NOG Mice
- (2013) Tanuja L. Gutti et al. AMERICAN JOURNAL OF PATHOLOGY
- Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections
- (2013) Keiichi Kosaka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery of MK-8742: An HCV NS5A Inhibitor with Broad Genotype Activity
- (2013) Craig A. Coburn et al. ChemMedChem
- Formulated Minimal-Length Synthetic Small Hairpin RNAs Are Potent Inhibitors of Hepatitis C Virus in Mice With Humanized Livers
- (2013) Han Ma et al. GASTROENTEROLOGY
- Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
- (2013) Anggakusuma et al. GUT
- Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
- (2013) Niu Shi et al. GUT
- Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells
- (2013) Anne Frentzen et al. HEPATOLOGY
- The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from theLos Alamosdatabank
- (2013) R. Alves et al. JOURNAL OF VIRAL HEPATITIS
- Completion of the entire hepatitis C virus life cycle in genetically humanized mice
- (2013) Marcus Dorner et al. NATURE
- Epidemiology and natural history of HCV infection
- (2013) Behzad Hajarizadeh et al. Nature Reviews Gastroenterology & Hepatology
- Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses
- (2013) Abeba Tesfaye et al. PLoS One
- Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
- (2013) M. J. Fuller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
- (2013) Alexander Vogt et al. VIROLOGY
- Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
- (2013) Stefania Paolucci et al. Virology Journal
- Hepatitis C virus infection and related liver disease: the quest for the best animal model
- (2013) Laurent Mailly et al. Frontiers in Microbiology
- Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
- (2012) Angela M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
- (2012) Zulema Plaza et al. ANTIVIRAL THERAPY
- A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes
- (2012) Sibylle Haid et al. GASTROENTEROLOGY
- Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
- (2012) Viet Loan Dao Thi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
- (2012) Tara L. Kieffer et al. PLoS One
- Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
- (2012) E. Giang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
- (2012) Trevor J. Morin et al. PLoS Pathogens
- A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
- (2011) Michael L. Washburn et al. GASTROENTEROLOGY
- The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
- (2011) Sandra Ciesek et al. HEPATOLOGY
- Impact of viral amino acid substitutions and host interleukin-28b polymorphism on replication and susceptibility to interferon of hepatitis C virus
- (2011) Nobuhiko Hiraga et al. HEPATOLOGY
- Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo
- (2011) Nobuhiko Hiraga et al. HEPATOLOGY
- A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
- (2011) Philip Meuleman et al. HEPATOLOGY
- In vivoevaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus
- (2011) Philip Meuleman et al. HEPATOLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- (−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
- (2011) Noémie Calland et al. HEPATOLOGY
- Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors
- (2011) S. Franco et al. JOURNAL OF VIRAL HEPATITIS
- A genetically humanized mouse model for hepatitis C virus infection
- (2011) Marcus Dorner et al. NATURE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success
- (2010) Rineke H. G. Steenbergen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Sustained Viral Response in a Hepatitis C Virus-Infected Chimpanzee via a Combination of Direct-Acting Antiviral Agents
- (2010) David B. Olsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
- (2010) Tetsuro Shimakami et al. GASTROENTEROLOGY
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
- (2010) Karl-Dimiter Bissig et al. JOURNAL OF CLINICAL INVESTIGATION
- Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice
- (2010) Ype P. de Jong et al. JOURNAL OF HEPATOLOGY
- Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice
- (2010) Eiji Ohara et al. JOURNAL OF HEPATOLOGY
- Positive Selection of Core 70Q Variant Genotype 1b Hepatitis C Virus Strains Induced by Pegylated Interferon and Ribavirin
- (2010) Fuat Kurbanov et al. JOURNAL OF INFECTIOUS DISEASES
- Species-Specific Regions of Occludin Required by Hepatitis C Virus for Cell Entry
- (2010) M. L. Michta et al. JOURNAL OF VIROLOGY
- Assembly of infectious hepatitis C virus particles
- (2010) Ralf Bartenschlager et al. TRENDS IN MICROBIOLOGY
- Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
- (2010) Julia Bitzegeio et al. PLoS Pathogens
- Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
- (2009) Antonio Ascione et al. GASTROENTEROLOGY
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women
- (2009) P. D. Dryer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pathogenesis of Hepatitis C Virus Infection in Tupaia belangeri
- (2009) Y. Amako et al. JOURNAL OF VIROLOGY
- Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
- (2009) J. M. Cuevas et al. JOURNAL OF VIROLOGY
- Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
- (2009) Alexander Ploss et al. NATURE
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
- (2009) R. E. Lanford et al. SCIENCE
- Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees
- (2008) S. S. Carroll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo
- (2008) Philip Meuleman et al. HEPATOLOGY
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
- (2008) Doug J. Bartels et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now